[go: up one dir, main page]

CO4840512A1 - Derivados fluorados de la vitamina d3 posiciones farmaceuticas elaboradas a partir de estos deriva dos. - Google Patents

Derivados fluorados de la vitamina d3 posiciones farmaceuticas elaboradas a partir de estos deriva dos.

Info

Publication number
CO4840512A1
CO4840512A1 CO97027698A CO97027698A CO4840512A1 CO 4840512 A1 CO4840512 A1 CO 4840512A1 CO 97027698 A CO97027698 A CO 97027698A CO 97027698 A CO97027698 A CO 97027698A CO 4840512 A1 CO4840512 A1 CO 4840512A1
Authority
CO
Colombia
Prior art keywords
deriva
vitamin
fluorine derivatives
pharmaceutical positions
developed
Prior art date
Application number
CO97027698A
Other languages
English (en)
Inventor
Bernard Michael Hennessy
Milan Radoje Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CO4840512A1 publication Critical patent/CO4840512A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Un compuesto de fórmula Ien donde R es hidrógeno, flúor o hidroxilo, y X es =CH2 o cuando R es hidroxilo, X es hidrógeno o =CH2 .
CO97027698A 1996-05-23 1997-05-21 Derivados fluorados de la vitamina d3 posiciones farmaceuticas elaboradas a partir de estos deriva dos. CO4840512A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1818796P 1996-05-23 1996-05-23

Publications (1)

Publication Number Publication Date
CO4840512A1 true CO4840512A1 (es) 1999-09-27

Family

ID=21786696

Family Applications (1)

Application Number Title Priority Date Filing Date
CO97027698A CO4840512A1 (es) 1996-05-23 1997-05-21 Derivados fluorados de la vitamina d3 posiciones farmaceuticas elaboradas a partir de estos deriva dos.

Country Status (30)

Country Link
US (1) US5888994A (es)
EP (1) EP0808831B1 (es)
JP (1) JP2858571B2 (es)
KR (1) KR100237523B1 (es)
CN (1) CN1081184C (es)
AR (1) AR007240A1 (es)
AT (1) ATE195514T1 (es)
AU (1) AU720098B2 (es)
BR (1) BR9703373A (es)
CA (1) CA2204478C (es)
CO (1) CO4840512A1 (es)
CZ (1) CZ157997A3 (es)
DE (1) DE69702812T2 (es)
DK (1) DK0808831T3 (es)
ES (1) ES2150719T3 (es)
GR (1) GR3034832T3 (es)
HR (1) HRP970274A2 (es)
HU (1) HUP9700927A3 (es)
IL (1) IL120842A0 (es)
MA (1) MA24345A1 (es)
NO (1) NO971934L (es)
NZ (1) NZ314838A (es)
PL (1) PL320131A1 (es)
PT (1) PT808831E (es)
SG (1) SG50831A1 (es)
TR (1) TR199700418A2 (es)
TW (1) TW374762B (es)
UY (1) UY24563A1 (es)
YU (1) YU19997A (es)
ZA (1) ZA974334B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO971934L (no) * 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger
DE69832699T2 (de) * 1997-05-16 2006-08-24 Woman & Infants Hospital Zyklische äther vitamin d3 verbindungen, 1alfa(oh) 3-epi-vitamin d3 verbindungen und deren verwendungen
US6017908A (en) * 1997-05-16 2000-01-25 Women And Infants Hospital 3-EPI vitamin D2 compounds and uses thereof
DE69814109T2 (de) * 1997-09-08 2004-02-26 F. Hoffmann-La Roche Ag 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analoga
AU3390400A (en) * 1999-03-05 2000-09-21 Johns Hopkins University, The Regulating skin appearance and composition with a fluorinated vitamin d3 analog compound
US7148211B2 (en) * 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
US20080293647A1 (en) 2004-11-12 2008-11-27 Luciano Adorini Combined Use Of Vitamin D Derivatives And Anti-Proliferative Agents For Treating Bladder Cancer
CA2882048C (en) 2006-02-03 2020-03-24 Proventiv Therapeutics, Llc Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
EP2679228B1 (en) 2006-06-21 2018-03-21 Opko Ireland Global Holdings, Ltd. Therapy using vitamin D repletion agent and vitamin D hormone replacement agent
WO2009047644A2 (en) 2007-04-25 2009-04-16 Cytochroma Inc. Method of treating vitamin d insufficiency and deficiency
KR101759244B1 (ko) 2007-04-25 2017-07-18 사이토크로마 인코포레이티드 비타민 d 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물
SI2552484T1 (sl) 2010-03-29 2020-07-31 Opko Ireland Global Holdings, Ltd. Postopki in sestavki za znižanje ravni paratiroidnega hormona
US8754067B2 (en) 2010-11-12 2014-06-17 Wisconsin Alumni Research Foundation 22-haloacetoxy-homopregnacalciferol analogs and their uses
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 d 방출 제형
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
CA3018019A1 (en) 2016-03-28 2017-10-26 Opko Ireland Global Holdings, Limited Methods of vitamin d treatment

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5039671A (en) * 1984-12-19 1991-08-13 Hoffmann-La Roche Inc. Trifluorinated-1α,25S-dihydroxy vitamin D3 compounds
US5145846A (en) * 1988-01-20 1992-09-08 Hoffmann-La Roche Inc. Vitamin D3 analogs
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
GB9007236D0 (en) * 1990-03-30 1990-05-30 Leo Pharm Prod Ltd Chemical compounds
GB9017890D0 (en) * 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
US5206230A (en) * 1991-06-05 1993-04-27 Daikin Industries, Ltd. Fluorine-containing vitamin D3 analogues and pharmaceutical composition containing the same
US5210237A (en) * 1991-08-27 1993-05-11 Daikin Industries, Ltd. Vitamin d3 analogues
US5200536A (en) * 1992-02-10 1993-04-06 Daikin Industries Ltd. Fluorine-containing vitamin D3 analogues
GB9206648D0 (en) * 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
ES2091515T3 (es) * 1992-05-20 1996-11-01 Hoffmann La Roche Analogos fluorados de la vitamina d3.
CA2096105A1 (en) * 1992-10-07 1994-04-08 Enrico Giuseppe Baggiolini (Deceased) Vitamin d3 fluorinated analogs
TW267161B (es) * 1992-11-20 1996-01-01 Hoffmann La Roche
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
US5384314B1 (en) * 1994-03-11 1997-08-05 Hoffmann La Roche 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol
NO971934L (no) * 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger

Also Published As

Publication number Publication date
HRP970274A2 (en) 1998-04-30
SG50831A1 (en) 1998-07-20
ATE195514T1 (de) 2000-09-15
CA2204478A1 (en) 1997-11-23
TR199700418A3 (tr) 1997-12-21
TR199700418A2 (xx) 1997-12-21
TW374762B (en) 1999-11-21
PL320131A1 (en) 1997-11-24
EP0808831A3 (en) 1999-02-03
DE69702812D1 (de) 2000-09-21
AR007240A1 (es) 1999-10-27
EP0808831A2 (en) 1997-11-26
DE69702812T2 (de) 2001-01-25
ES2150719T3 (es) 2000-12-01
GR3034832T3 (en) 2001-02-28
ZA974334B (en) 1997-11-24
NO971934D0 (no) 1997-04-25
US5888994A (en) 1999-03-30
YU19997A (sh) 1999-07-28
BR9703373A (pt) 1998-09-15
CZ157997A3 (en) 1997-12-17
HUP9700927A3 (en) 1999-07-28
CN1081184C (zh) 2002-03-20
NO971934L (no) 1997-11-24
PT808831E (pt) 2000-12-29
KR100237523B1 (ko) 2000-01-15
NZ314838A (en) 1998-01-26
HUP9700927A2 (hu) 1998-01-28
IL120842A0 (en) 1997-09-30
DK0808831T3 (da) 2001-01-02
AU720098B2 (en) 2000-05-25
CA2204478C (en) 2006-11-21
EP0808831B1 (en) 2000-08-16
UY24563A1 (es) 2000-12-29
JPH1045712A (ja) 1998-02-17
HU9700927D0 (en) 1997-07-28
CN1169425A (zh) 1998-01-07
AU2357297A (en) 1997-11-27
JP2858571B2 (ja) 1999-02-17
MX9703776A (es) 1998-06-30
KR970074763A (ko) 1997-12-10
MA24345A1 (fr) 1998-07-01

Similar Documents

Publication Publication Date Title
CO4840512A1 (es) Derivados fluorados de la vitamina d3 posiciones farmaceuticas elaboradas a partir de estos deriva dos.
YU47204B (sh) Derivati didehidro-vitamina d3
ES2187660T3 (es) Derivados de rapamicina.
ES2134847T3 (es) Derivados de taxol.
TR199800585T2 (xx) COX-2 �nhibit�rleri Olarak (Metils�lfonil)Fenil-2-(5H)-Furanonlar.
DK0767654T3 (da) Antiseptisk tandplejemiddel
TR199700844T1 (xx) Pirazolil-Benzoil T�revleri.
AR038427A2 (es) Compuestos 15-alquil-14-hidroxilo de marcfortina y parahercuamida
SE8503922L (sv) Analgetiska 1,2-bensisotiazol-3-ylpiperazin-derivat
NO963370D0 (no) Nye mercaptoacetylamido-1,3,4,5-tetrahydro-benzo[cÅazepin-3-on-disulfidderivater som er anvendbare som inhibitorer av enkefalinase og ACE
CO4950531A1 (es) Analogos de la vitamina d3 composciiones farmaceuticas que los contienen
BR9714650A (pt) " derivados farmacêuticos de ácido aminofosfÈnico "
EE9800435A (et) H+, K+-ATPaasi inhibiitorite manustamise reziim
ATE127791T1 (de) Quinolin-3-carboxanilid-derivate.
ES2151977T3 (es) Inhibidores de accion doble que contienen 1,2-diazepina.
NO982229D0 (no) Svovelholdige di-tert-butylfenol-forbindelser anvendbare som antiinflammatoriske midler
DK1204658T3 (da) Benzofurylpiperazin-serotoninagonister
YU48915B (sh) Sulfonilkarbamid i postupak za njegovo dobijanje
NO981340L (no) Stabiliserte fosfolipidsammensetninger
CA2219455A1 (fr) Utilisation de derives de pyrrolidine au traitement de l'alcoolisme
DE69430074D1 (de) Analgetische 4-arylisoindolen
NO944309D0 (no) Fremgangsmåte for fremstilling av ribonukleotidreduktase-inhibitorer
DE69614552D1 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
DK0673913T3 (da) Calcium-alkalimetalcitratforbindelser samt deres anvendelse som lægemidler
NO984043L (no) Ensileringsmiddel